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Abstract
Background: One of the main indicators of the welfare of a nation is the index of women's health status. Women's health (or health care) is the key 
factor, on which depends the happiness and wellbeing of each family. During her life cycle, a woman passes through several stages that affect the health 
of the genital organs: menstruation, fertility, pregnancy, childbirth, and menopause. When ladies are facing these situations, most of them remember 
that they followed some drug treatments for long period of time. This scientific study represents an analysis of the pharmaceutical preparations and their 
forms used in gynecology practice. According to records from the State Nomenclature of the Republic of Moldova, research methodology was developed 
(using the following criteria:  anatomical therapeutic chemical classification, dose, division, country and industrial pharmaceutical company producer, 
producer's price, terms of validity),  based on local authors publications. The research study was conducted and reveals the information gathered before 
(until) 31st of March, 2016. 
Conclusion: Taking into consideration all pharmaceutical forms registered in the State Register of the Republic of Moldova, used in gynecological practice 
can be divided into: a) pills, b) pessaries, c) injection solutions. The Republic of Moldova is located at the top of the list of the 21-producing countries, 
which have registered pharmaceutical forms, used in gynecological practice. Domestic producers of medicines are covering approximately 10.98% of 
pharmaceutical products segment.
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Introduction
One of the main indicators of well-being of a country is the 
health of women who live in it.  And on this factor depends the 
happiness of every family. The statistic information attests 
the fact that women's health in the Republic of Moldova is 
alarming. The number of women of childbearing age suffe-
ring from various diseases is growing. At present stage, every 
second woman reaches reproductive age with seriously modi-
fied maternal land [3, 6, 12]. Only in the last 10 years, in the 
Republic of Moldova, sterile couples increased approximately 
twice and reached the number of 16.0% [1], one of the main 
causes  of  infertility  being  consequences  or  complications 
of gynecological pathologies [5, 7].
During her life cycle,  a woman passes through  several 
stages  that affect her genital health: menstruation, fertili-
ty, pregnancy, childbirth, menopause,  and then we  should 
not forget that some of them followed some drug treatments 
for long period of time. 
Some authors  state that,  in  general,  gynecological  di-
seases  can be divided into  three groups:  a)  inflammatory 
diseases of the female genitals, b) diseases caused by endo-
crine disorders, c) hyper-plastic, degenerative and neoplastic 
diseases in sexual field [4, 13]. 
Taking into consideration  this fact, the multitude 
of diseases and pathological  gynecological conditions, as-
sumes using  in  their treatment various types of  formulati-
ons and active ingredients, and not only from the G-code Ge-
nitourinary Unit and sex hormones, but some other codes as 
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Material and methods
As materials served the information regarding registrati-
on of medicinal preparations and their pharmaceutical forms 
taken from State Nomenclature of the Republic of Moldo-
va (producers analysis results and results of production in this 
specific segment of medicines, prices of manufactured pro-
ducts and validity period, stated by the producer).
The research methodology was developed based on  lo-
cal  author’s  publications  [2, 12]  using the following me-
thods: analytical, descriptive statistics, comparison, price ana-
lysis, etc. The research study was conducted and reveals the 
information gathered until 31st of March, 2016.
Results and discussions
According to ATC List with a total of 528 preparations, G-
code class Genitourinary Unit and sex hormones,  includes 
4 sub-codes: 
-G01 Gynecological antiinfectives and antiseptics,
-G02 Other gynecological preparations, -G03 Sex hormones 
and modulators of the genital system,
-G04 medication of urinary system (urological) [8].
The pharmaceutical forms used in gynecological practi-
ce, according to the ATC, are shown in figure 1.
As shown in figure 1, according to ATC classification, sub-
code  -G03  Sex hormones and modulators of the  genital 
system accumulate the highest number of registered prepa-
rations.
Preparations used in gynecological practice, registered 
in Moldova, are present in the following pharmaceutical for-
ms: vaginal spray-1-topical solution, oral solution-3, cutane-
ous solution-2, vaginal solution-1, implants-2, effervescent 
granules-1, vaginal gel-5, oral gel-1, gel-8, drinkable drops-1, 
oral paste-1,  fragmented vegetal product-3, oral drops, so-
lution-11, syrups-3, dragees-18,   ovules  -63, pessaries-19, 
capsules-71 (including,  gastro-resistant soft capsule-1, soft 
capsules-9, capsules with long drug expiration-3capsules with 
modified release-15, vaginal capsules-14) vaginal cream-5, 
cream-3,  trans-dermal patch-2, tablets-218 (incl. chewable 
tablets-3, extended release tablets-8, tablets-108, extended 
release tablets-2, effervescent tablets-1, lozenges-3, orodis-
persible tablets-6, vaginal tablets-23, homeopath tablets-3), 
injectable solutions-45 (including injectable solution in a car-
tridge-6, solution for injection in pre-filled syringe-5, solution 
for injection in pre-filled pen-5, oil injection-4) lyophilized + 
solvent / solution for injection-11, powder + solvent / solution 
for injection-17, suspension for injection-4, solution for in-
fusion-14, powder / vaginal solution-2, lyophilized powder / 
injection-1, releasing intrauterine system-2, releasing vaginal 
system-1 [8,10].
According to the records from  the State Nomenclatu-
re of the Republic of Moldova of March 31st, 2016, from the 
total  share of  authorized medicinal products, preparations 
used in gynecological practice were 5.54%. From these pre-
parations, pharmaceutical forms can be divided into: soluti-
Fig. 1.  Presentation of ATC code - G Unit preparations Genitourinary system and sex hormones.
Fig. 2.  Pharmaceutical forms used in gynecological practice, according  the State Nomenclature of the Republic of Moldova.
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ons for topical use, irrigation - 0.95%, vaginal tablets - 7.62%, 
ointments, gels, vaginal creams - 6.03%, vaginal  implants - 
0.63%, suppositories, pessaries - 15.53%, releasing intrauteri-
ne systems - 0.95%, transdermal patch - 0.63%, vaginal aero-
sol - 0.32%, vaginal capsules - 5.71%, tablets - 24%, injectable 
solutions - 15% , injectable suspensions - 1.27%,  powder / 
vaginal solution - 9.21%, dragees - 5.08% [8.10].
Formulations  (pharmaceutical forms) used in  gyneco-
logical practice, according to the State Nomenclature of the 
Republic of Moldova are presented in figure 2. 
The data  shown in figure  2 proves  that  ovules,  ta-
blets and injectable solutions are in the top of pharmaceutical 
forms, used in the treatment of gynecological diseases, recor-
ded in the Republic of Moldova [8, 10].
Medicine producers (Drug makers)
A. Countries (figure 3)
From the number  of medicines  used  in  gynecolo-
gical  practice, in Moldova  were registered  preparati-
ons  from 21 countries, in  the top 10  -  the first position  is 
held by the Republic of Moldova - with 18.53% (58medici-
nes - produced and registered), Switzerland holds the second 
position with  12,78% (40 medicines), on the third place 
is Hungary and Germany with 11.50% each (36 medicines) 
[8,10].
Fig. 3.  Top 10 countries producing pharmaceutical forms, used 
in gynecological practice registered in the Republic of Moldova.
As to information reflected in figure 3, local producers co-
ver production of pharmaceutical forms, used in gynecologi-
cal practice by 10.98%.
B. Pharmaceutical industry, producing enterprise 
Fig. 4.  Top 10 Pharmaceutical industrial producing enterprises, 
used in gynecological practice, registered  
in the Republic of Moldova.
The leading pharmaceutical company producing industri-
al products used in gynecological practice registered in the 
Republic of Moldova, is Gedeon Richter PLC, Hungary; fol-
lowed by industrial enterprises: FARMAPRIMSRL, Moldova 
and Bayer Pharma AG, Germany (fig. 4) [8,10].
Terms of validity (Expiration date)
One  of the decisive factors  ensuring competitive-
ness of medicines is their quality. Many pharmaceutical for-
ms are in native equilibrium, but degrade as disposal of free 
energy, being in a phase when their therapeutic value decre-
ases. Therefore, an important parameter of the quality of the 
pharmaceutical forms is the term of expiry, determined throu-
gh different experimental methods, e.g. "Method of accelerated 
aging" or through other degrading methods [9].
Fig. 5.  The expiration date as a parameter of the pharmaceutical 
forms quality used in gynecological practice, registered  
in the Republic of Moldova.
As shown in figure 5 the longest expiration date stated by 
the manufacturer - 60 months, 74 pharmaceutical forms have 
this validity terms (e.g. suspension for injection - Depo-Prove-
ra, 150 mg / mL, 1 mL N1, G03AC06, Medroxyprogesteronum, 
Pharmacia NV / SA, Belgium); - 12 pharmaceutical forms de-
clared the expiration date of 48 months (e.g., Logest® tablets, 
0.02 mg + 0.075 mg, N21, G03AA10, Ethinylestradiolum + 
Gestodenum, Bayer Schering Pharma AG (Bayer Schering 
Pharma AG prod.: Germany; Delpharm SAS Lille, France), 
Germany); - 1 pharmaceutical form announced the expiration 
date of 40 months ( releasing vaginal system - NuvaRing®, 11.7 
mg + 2.7 mg, N1, G02BB01, Etonogestrelum + Ethinylestra-
diolum, Schering-Plough Central East AG (prod.: Organon 
(Ireland) Ltd., Ireland Organon NV, Netherlands), Switzer-
land); - 272 pharmaceutical forms stated expiration date - 36 
months (e. g.   transdermic patch (STT) - Climara®, 3.8 mg 
(50 mcg / 24 h), N4, G03CA03, Estradiolum, Bayer Schering 
Pharma AG (prod.: 3M Drug Delivery System, USA), Ger-
many); - 2 pharmaceutical forms stated terms of validity - 30 
months; - 163 pharmaceutical forms announced expiration 
date - 24 months (e.g. Pessaries - Dalacin vaginal pessaries, 
100 mg, N3, G01AA10, Clindamycinum, Pharmacia & Upjohn 
Company, USA); - 2 pharmaceutical forms declared expiration 
date - 18 months (e.g. Vaginal soft capsules - Polygynax® Virgo, 
35000 + 35000 UI UI UI + 100000, N3x2, G01A, Polymyxi-
num Neomycinum + B + Nystatinum, Laboratoire Innotech 
International (prod.: Innothera Chouzy, France), France) [8].
Producer's prices
A very important index that describes the accessibility of 
a proper and efficient treatment (and correlation "cost-effec-
tiveness"), is the price of medicines input by the manufactu-
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rer. This way, the price declared by the producer in decreasing 
for some pharmaceutical forms used in gynecological prac-
tice (fig. 6):
1. Solution for injection in pre-filled syringe  - Elonva®, 
150 mcg / 0.5 ml, 0.5 ml, N1, G03GA09, Corifollitropinum al-
pha, Schering-Plough Central East AG (prod.: Organon (Ire-
land) Ltd., Ireland; VetterPharma-FERTIGUNG GmbH & 
Co.KG, Germany), Switzerland, term of validity - 36 mon-
ths, producer's price (ex works) - € 455.19 or 8835.60 MDL.
2. Solution for injection in pre-filled syringe  - Elonva®, 
100 mcg / 0.5 ml, 0.5 ml, N1, G03GA09, Corifollitropinum al-
pha, Schering-Plough Central East AG (prod.: Organon (Ire-
land) Ltd., Ireland; VetterPharma-FERTIGUNG GmbH & 
Co.KG, Germany), Switzerland, term of validity - 36 mon-
ths, producer's price (ex works) - € 412.03 or 7997,83MDL.
3. Solution for injection in pre-filled pen - Gonal-f® 900 IU 
(66 mcg), 1.5 ml,  N1 G03 GA05,  Follitropinum  alpha, 
Merck Serono S.A. (Prod .: Merck Serono S.P.A., Italy), Swit-
zerland, term of validity  - 24 months, producer's price  (ex 
works) or -310.15 USD 6176.11 MDL.
4.  Powder +  solvent  /  solution for injection  - Bravel-
le  75 IU N5x2  +  1ml, N5x2,  G03GA04, Urofollitropi-
num, Ferring GmbH, Germany, term of validity - 24 mon-
ths, producer's price (ex works) - € 159.03 and 3420.23 MDL.
5.  Solution for injection in  cartridge  -  Puregon®,  600 
IU / 0.72 ml, 0.780 ml, N1, G03GA06, Follitropi beta-num, 
Schering-Plough Central East AG  (prod.:  Organon (Ire-
land) Ltd., Ireland Vetter FERTIGUNG-Pharma GmbH & 
Co.KG, Germany), Switzerland, term of validity - 36 mon-
ths, producer's price (ex works) - € 162.75 or 3159.11 MDL.
6. Tablets - Esmya®, 5 mg, N14x2, G03AD02, Uliprista-
lum, Gedeon Richter PLC, Hungary, term of validity - 24 mon-
ths, producer's price (ex works) - € 115.69 or 2591.33 MDL.
7.  Releasing  intrauterine  system  -  Jaydess®, 13.5 mg, 
N1,  G02BA03, Levonorgestrelum, Bayer  Pharma AG 
(prod.: Bayer Oy, Finland), Germany,  term of validity  - 24 
months, producer's price  (ex works)  - € 121.30 or 2354.53 
MDL.
8.  Solution for injection in  pre-filled pen  - Gonal-
f® 300 IU (22 mcg), 0.5 ml, N1 G03 GA05, Follitropinum alp-
ha, Ares Trading S.A. (Prod.: Merck Serono S.P.A., Italy), Swit-
zerland,  term of validity  - 24 months, producer's price  (ex 
works) - $ 103.35 or 2058.04 MDL.
9.  Releasing  intrauterine  system  - Mirena®, 52 mg 
(20 mcg  / 24 hours), N1, G03AC03, Levon-gestrelum, Ba-
yer Oy, Finland, term of validity - 36 months, producer's pri-
ce (ex works) - 86.5 EUR or 1679.03 MDL.
10. Films - Clostilbegyt, 50 mg, N10, G03GB02, Clomife-
num, Egis Pharmaceuticals PLC, Hungary, term of validity - 60 
months, producer's price (ex works) - $ 2.76 or 55.18 MDL.
The lowest price can be seen at pharmaceutical form - vagi-
nal tablets - Clotrimazol MCC 100 mg, N6x2, G01AF02, Clo-
trimazolum, Magistra C & C SRL, SC, Romania, term of vali-
dity - 24 months,producer's price (ex works) MDL - 8.35, EUR 
- 0.43 [8,10].
The number and prices of products manufactured and 
registered in the Republic of Moldova varies depending on 
producing enterprises:  lower price <50.00 MDL  -  37 me-
dicines >50.00 <100.00 MDL –  66 medicines >100 <200 
MDL - 76 medicines, > 200 <400 MDL - 35 medicines, > 400 
<1000 MDL - 6 medicines, over > 1000 MDL - 16 medicines.
Conclusions
1. In the Republic of Moldova, according to ATC classificati-
on code G-Unit genitourinary system and sex hormones, 
includes 4 sub-codes that represent the following sub-code 
-G03 Sex hormones and modulators of the genital system 
and accumulates the highest number of registered medicines, 
the lowest is sub-code ‒ G 02 Other gynecological medicines.
2. From pharmaceutical forms registered in the State Nomen-
clature of the Republic of Moldova used in gynecological 
practice, the largest number goes to: a) tablets, b) ovules 
and c) injectable solutions.
3. Moldova is located at the head of the 21 producing coun-
tries, which have registered pharmaceutical forms used in 
gynecological practice. Domestic producers of medicines 
are covering 10.98 % from this segment of pharmaceutical 
market.
Fig. 6.  Estimation of the preparations used in gynecological practice,  
registered in the Republic of Moldova, according to price of the producer.
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4. The biggest amount of medicines used in gynecological
practice and registered in Moldova lies with the company
manufacturing industrial medicines Gedeon Richter PLC,
Hungary.
5. The term of validity (expiration date) of the pharmaceu-
tical forms used in gynecological practice declared by the
manufacturer vary depending on the nature of the active
substance and pharmaceutical form from 60 months till
18 months.
6. Producer's price for pharmaceutical forms used in gyne-
cological practice varies between 8.35 MDL and 8835.60
MDL. Prices of the medicines used in gynecological practice
produced by domestic medicine manufacturing enterprises
have medium range of  competitiveness  and vary from -
13.22 MDL to - 1800.00 MDL.
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